Skip to content
GenoLensGenoLens

SEMA4A

Chr 1q22

semaphorin 4A

Aliases:
SemB, FLJ12287, CORD10
MANE:
ENST00000368285.8

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Retinal disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Glaucoma (developmental)

  • Structural eye disease

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • retinitis pigmentosa

    0.68
  • Cone rod dystrophy

    0.65
  • cone-rod dystrophy

    0.39
  • Rod-cone dystrophy

    0.39
  • Retinal dystrophy

    0.38
  • familial colorectal cancer type X

    0.37
  • helicoid peripapillary chorioretinal degeneration

    0.36
  • Posterior column ataxia - retinitis pigmentosa

    0.19
  • eye disorder

    0.19
  • optic atrophy

    0.16

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Semaphorin-4A

Cell surface receptor for PLXNB1, PLXNB2, PLXNB3 and PLXND1 that plays an important role in cell-cell signaling (By similarity). Regulates glutamatergic and GABAergic synapse development (By similarity). Promotes the development of inhibitory synapses in a PLXNB1-dependent manner and promotes the development of excitatory synapses in a PLXNB2-dependent manner (By similarity). Plays a role in priming antigen-specific T-cells, promotes differentiation of Th1 T-helper cells, and thereby contributes to adaptive immunity (By similarity). Promotes phosphorylation of TIMD2 (By similarity). Inhibits angiogenesis (By similarity). Promotes axon growth cone collapse (By similarity). Inhibits axonal extension by providing local signals to specify territories inaccessible for growing axons (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.